Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,100 | 21,700 | 35,252 | 37,834 | 43,209 |
| Marketable Securities | 6,012 | 9,212 | 4,211 | 9,263 | 9,316 |
| Receivables | 38 | N/A | 7 | 64 | 7 |
| Other current assets | 190 | 591 | 534 | 804 | 368 |
| TOTAL | $27,340 | $31,503 | $40,004 | $47,965 | $52,900 |
| Non-Current Assets | |||||
| PPE Net | 51 | 59 | 67 | 72 | 70 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 209 | 209 | 209 | 209 | 209 |
| TOTAL | $3,468 | $3,476 | $3,484 | $3,489 | $3,487 |
| Total Assets | $30,808 | $34,979 | $43,488 | $51,454 | $56,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,865 | 9,559 | 8,870 | 9,262 | 6,239 |
| Accrued Expenses | 418 | 178 | 897 | 503 | 353 |
| TOTAL | $9,283 | $9,737 | $9,767 | $9,921 | $6,748 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 156 | 156 |
| Other Non-Current Liabilities | 11 | 2,663 | 2,674 | 2,639 | 2,651 |
| TOTAL | $11 | $2,663 | $2,674 | $2,639 | $2,651 |
| Total Liabilities | $9,294 | $12,400 | $12,441 | $12,560 | $9,399 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,913 | 71,193 | 71,023 | 71,023 | 69,704 |
| Common Shares | 72 | 71 | 71 | 71 | 70 |
| Retained earnings | -380,505 | -379,001 | -369,887 | -361,512 | -351,265 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $21,514 | $22,579 | $31,047 | $38,894 | $46,988 |
| Total Liabilities And Equity | $30,808 | $34,979 | $43,488 | $51,454 | $56,387 |